Lu, Xin-An
4919  Ergebnisse:
Personensuche X
?
3

Factors associated with treatment response to CD19 CAR-T th..:

Zhang, Xian ; Yang, Junfang ; Li, Jingjing...
Cancer Immunology, Immunotherapy.  71 (2021)  3 - p. 689-703 , 2021
 
?
5

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cell..:

Zhao, Xiangyu ; Yang, Junfang ; Zhang, Xian...
Molecular Therapy - Oncolytics.  18 (2020)  - p. 272-281 , 2020
 
?
8

Autologous CD19-directed chimeric antigen receptor-T cell i..:

Bao, Fang ; Wan, Wei ; He, Ting...
Cancer Gene Therapy.  26 (2019)  7-8 - p. 248-255 , 2019
 
?
9

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Tar..:

Ying, Zhitao ; He, Ting ; Wang, Xiaopei...
Molecular Therapy - Oncolytics.  15 (2019)  - p. 60-68 , 2019
 
?
10

Endostatin sensitizes p53-deficient non-small-cell lung can..:

Jia, Lin ; Lu, Xin-an ; Liu, Guanghua...
The Journal of Pathology.  243 (2017)  2 - p. 255-266 , 2017
 
?
11

The novel anti-CD19 chimeric antigen receptors with humaniz..:

Qian, Liren ; Li, Dan ; Ma, Lie...
Cellular Immunology.  304-305 (2016)  - p. 49-54 , 2016
 
?
 
?
14

Acyl and Silyl Group Effects in Reactivity-Based One-Pot Gl..:

Hsu, Yun ; Lu, Xin-An ; Zulueta, Medel Manuel L....
Journal of the American Chemical Society.  134 (2012)  10 - p. 4549-4552 , 2012
 
1-15